Karyopharm Therapeutics Inc.
KPTI
$5.46
$0.101.87%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -65.64% | -66.02% | -52.93% | -43.21% | -35.90% |
| Total Receivables | 0.31% | -14.67% | 13.39% | 10.03% | -16.20% |
| Inventory | -15.11% | 43.61% | 72.23% | 55.73% | 50.47% |
| Prepaid Expenses | -45.57% | -42.37% | -33.55% | 13.24% | 10.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -95.45% | -93.94% |
| Total Current Assets | -51.42% | -53.07% | -39.39% | -33.10% | -29.81% |
|
|
|||||
| Total Current Assets | -51.42% | -53.07% | -39.39% | -33.10% | -29.81% |
| Net Property, Plant & Equipment | 55.86% | 40.17% | 30.20% | 28.72% | -43.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.68% | 2.81% | 2.20% | 0.43% | 30.57% |
| Total Assets | -49.21% | -50.99% | -37.54% | -31.62% | -29.81% |
|
|
|||||
| Total Accounts Payable | -6.76% | -7.15% | 16.79% | 63.53% | 513.26% |
| Total Accrued Expenses | 32.38% | 26.34% | 4.23% | -1.21% | -10.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -74.86% | 115.32% | -72.93% | -86.76% | 14.80% |
| Total Finance Division Other Current Liabilities | -8.88% | 7.15% | -4.76% | -0.79% | -13.06% |
| Total Other Current Liabilities | -8.88% | 7.15% | -4.76% | -0.79% | -13.06% |
| Total Current Liabilities | 41.73% | 72.19% | 38.31% | 32.79% | -0.94% |
|
|
|||||
| Total Current Liabilities | 41.73% | 72.19% | 38.31% | 32.79% | -0.94% |
| Long-Term Debt | -5.24% | -14.69% | -24.79% | -22.07% | -12.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 554.55% | 244.21% | 140.66% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -6.19% | -45.06% | 225.68% | 1,434.97% | 1,548.39% |
| Total Liabilities | 4.69% | -0.67% | -10.66% | -6.96% | -5.73% |
|
|
|||||
| Common Stock & APIC | 1.10% | 1.20% | 1.87% | 1.98% | 2.06% |
| Retained Earnings | -8.13% | -8.23% | -4.10% | -5.14% | -6.05% |
| Treasury Stock & Other | -16.67% | 58.51% | 38.03% | -121.12% | 70.08% |
| Total Common Equity | -68.66% | -80.81% | -21.86% | -36.57% | -59.02% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -68.66% | -80.81% | -21.86% | -36.57% | -59.02% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -68.66% | -80.81% | -21.86% | -36.57% | -59.02% |
|
|
|||||